Clare Gould

885 total citations
12 papers, 457 citations indexed

About

Clare Gould is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Clare Gould has authored 12 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Clare Gould's work include Lymphoma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (4 papers). Clare Gould is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (4 papers). Clare Gould collaborates with scholars based in Australia, United States and Canada. Clare Gould's co-authors include Maher K. Gandhi, Colm Keane, Sanjiv Jain, Dipti Talaulikar, Joshua W.D. Tobin, Frank Vari, Erica Han, Simone Birch, Mark Hertzberg and Qingyan Cui and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Clare Gould

12 papers receiving 456 citations

Peers

Clare Gould

ONCOL

IMMUN

PFM

GENET

Erica Han Australia

Kirsty Wienand United States

Qi-Chun Cai China

Tammy Price-Troska United States

Yuki Komabayashi Japan

Yngvild Nuvin Blaker Norway

W. Klapper Germany

Ines Pfeil Germany

Matias Autio Finland

Avery Polk United States

Erica Han Australia

Clare Gould

304 ×0.9

ONCOL

276 ×1.0

IMMUN

174 ×0.9

PFM

58 ×1.0

32 ×0.7

GENET

Citations per year, relative to Clare Gould Clare Gould (= 1×) peers Erica Han

Countries citing papers authored by Clare Gould

Since Specialization

Citations

This map shows the geographic impact of Clare Gould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Gould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Gould more than expected).

Fields of papers citing papers by Clare Gould

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Gould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Gould. The network helps show where Clare Gould may publish in the future.

Co-authorship network of co-authors of Clare Gould

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Gould. A scholar is included among the top collaborators of Clare Gould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Gould. Clare Gould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gould, Clare, et al.. (2024). Observations from a national sample exchange program for molecular haematology testing. Pathology. 56(4). 540–547. 1 indexed citations

Gould, Clare, Stephen Lade, Maher K. Gandhi, et al.. (2021). Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. British Journal of Haematology. 195(1). 113–118. 8 indexed citations

Barraclough, Allison, Musa Alzahrani, Mark Bishton, et al.. (2019). COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study. Blood Advances. 3(13). 2013–2021. 28 indexed citations

Gould, Clare, Colm Keane, Valentine Murigneux, et al.. (2019). B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL. Blood. 134(Supplement_1). 2778–2778. 2 indexed citations

Keane, Colm, Joshua W.D. Tobin, Jay Gunawardana, et al.. (2019). The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma. European Journal Of Haematology. 103(3). 200–207. 37 indexed citations

Vari, Frank, Colm Keane, Mark Hertzberg, et al.. (2018). Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood. 131(16). 1809–1819. 231 indexed citations

Keane, Colm, Soi Cheng Law, Clare Gould, et al.. (2018). Elevated LAG-3 Expression in the Tumor Microenvironement of Patients with DLBCL Is Associated with a Non-GCB Phenotype and Poor Prognosis. Blood. 132(Supplement 1). 1576–1576. 1 indexed citations

Cui, Qingyan, Frank Vari, Alexandre S. Cristino, et al.. (2018). Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma. Oncotarget. 9(78). 34644–34657. 16 indexed citations

Gandhi, Maher K., Colm Keane, Joshua W.D. Tobin, et al.. (2017). The impact of EBV upon the tumor microenvironment and mutational profile of primary CNS lymphoma in PTLD. Blood. 130. 2731–2731. 2 indexed citations

10.

Tobin, Joshua W.D., Colm Keane, Peter Mollee, et al.. (2017). The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma. Blood. 130(Suppl_1). 728–728. 1 indexed citations

11.

Keane, Colm, Clare Gould, Kimberley Jones, et al.. (2016). The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma. Clinical Cancer Research. 23(7). 1820–1828. 63 indexed citations

12.

Keane, Colm, Frank Vari, Mark Hertzberg, et al.. (2015). Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study. The Lancet Haematology. 2(10). e445–e455. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact